Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Matt_Sause
|
| gptkbp:division |
gptkb:Roche_Group
|
| gptkbp:focusArea |
clinical chemistry
molecular diagnostics diabetes care immunoassays in vitro diagnostics point-of-care testing |
| gptkbp:foundedYear |
1968
|
| gptkbp:headquartersLocation |
gptkb:Basel,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Roche Diagnostics
|
| gptkbp:industry |
diagnostics
|
| gptkbp:keyPerson |
gptkb:Thomas_Schinecker
|
| gptkbp:market |
global
|
| gptkbp:notableProduct |
gptkb:Accu-Chek
gptkb:Elecsys gptkb:LightCycler gptkb:VENTANA gptkb:cobas_systems |
| gptkbp:numberOfEmployees |
over 30,000
|
| gptkbp:operatesIn |
over 100 countries
|
| gptkbp:parentCompany |
gptkb:Roche
|
| gptkbp:products |
reagents
diagnostic instruments test kits |
| gptkbp:revenue |
over 13 billion CHF (2022)
|
| gptkbp:website |
https://diagnostics.roche.com/
|
| gptkbp:bfsParent |
gptkb:Roche_Diagnostics_North_America
gptkb:Mannheim |
| gptkbp:bfsLayer |
5
|